MENU
SONN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Sonnet BioTherapeutics Holdings (SONN) Ownership - Who owns Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company... Show more
Profile
Industry
N/A
Address
100 Overlook Center
Phone
+1 609 375-2227
Employees
12
Web
https://www.sonnetbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.17M
P/E Ratio
0.29
Total Cash
4.86M
Projected Growth
N/A
Total Debt
110.96K
Revenue
1M
Risk (Beta)
1.30
Dividend Yield
N/A
Total Cash/Share
1.59
Total Debt/Equity
N/A
Revenue/Share
0.96 USD as % of share price
Fundamentals
SONN
Capitalization
4.17M
P/E Ratio
0.29
Risk (Beta)
1.30
Dividend Yield
N/A
Total Cash
4.86M
Total Cash/Share
1.59
Total Debt
111K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.96%
Revenue
1M
ROE
N/A
Book Value
4.04M
P/B Ratio
1.03
Cash Flow
N/A
Earnings
-10.45
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
300
Current Ratio
2.15
Current Revenue Per Employee
76923.08
Dividends Per Share - Security
N/A
EBITDA
-13.33M
Float
N/A
Float - Current
N/A
Gross Income Margin
68.36
Revenue To Assets
-150.63
Shares Held By Institutions
146K
Shares Outstanding - Current
3.07M
Total Liabilities
3.15M
Total Volume MTD
N/A
Value
1
Gain YTD
-6.849
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the development of biologic drugs with enhanced single or bispecific mechanisms
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
100 Overlook Center
Phone
+1 609 375-2227
Employees
12
Web
https://www.sonnetbio.com